Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Glossary:TAG-00127-Com-meC

From GxPlex

Revision as of 13:50, 16 July 2026 by Gxplex admin (talk | contribs) (1 revision imported)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Glossary > Systems validation

Systems validation
Tag-ID TAG-00127-Com-meC
English Computerised systems validation / Computer system validation
EN Abbr. CSV
French Validation des systèmes informatisÊs / Validation informatique / Validation des systèmes informatiques
FR Abbr. VSI
German Validierung computergestĂźtzter Systeme / Computervalidierung / Systemvalidierung
DE Abbr. CSV

References

 ScopeDocument partLanguageDocument
EU EMA/INS/GCP/112288/2023 - Guideline on computerised systems and electronic data in clinical trials 2023 4.2G4.2ENEU EMA/INS/GCP/112288/2023 - Guideline on computerised systems and electronic data in clinical trials 2023
EU EMA/INS/GCP/112288/2023 - Guideline on computerised systems and electronic data in clinical trials 2023 4.6G4.6ENEU EMA/INS/GCP/112288/2023 - Guideline on computerised systems and electronic data in clinical trials 2023
EU EMA/INS/GCP/112288/2023 - Guideline on computerised systems and electronic data in clinical trials 2023 A4.13GA4.13ENEU EMA/INS/GCP/112288/2023 - Guideline on computerised systems and electronic data in clinical trials 2023
GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447 System SecurityGSystem SecurityENGBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447
ICH ICH E6 Guideline R3 (2025) GLOSSARY - Computerised Systems ValidationGGLOSSARY - Computerised Systems ValidationENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.12.10GIII. Annex 1 2.12.10ENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) III. Annex 1 3.16.1 For systems used or deployed by the investigator/institutionGIII. Annex 1

3.16.1

For systems used or deployed by the investigator/institution
ENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) III. Annex 1 4.3GIII. Annex 1 4.3ENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) III. Annex 1 4.3.3GIII. Annex 1 4.3.3ENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) III. Annex 1 4.3.4GIII. Annex 1 4.3.4ENICH ICH E6 Guideline R3 (2025)
ICH ICH E6 Guideline R3 (2025) III. Annex 1 4.3.8GIII. Annex 1 4.3.8ENICH ICH E6 Guideline R3 (2025)
USA 21 CFR Part 11 09-Apr-2025 § 11.10G§ 11.10ENUSA 21 CFR Part 11 09-Apr-2025
USA 21 CFR Part 11 09-Apr-2025 § 11.30G§ 11.30ENUSA 21 CFR Part 11 09-Apr-2025
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - validationHMGlossary - validationENWHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995